EP1165598A4 - Inhibiteur des plaquettes d'ankylostome - Google Patents

Inhibiteur des plaquettes d'ankylostome

Info

Publication number
EP1165598A4
EP1165598A4 EP00918509A EP00918509A EP1165598A4 EP 1165598 A4 EP1165598 A4 EP 1165598A4 EP 00918509 A EP00918509 A EP 00918509A EP 00918509 A EP00918509 A EP 00918509A EP 1165598 A4 EP1165598 A4 EP 1165598A4
Authority
EP
European Patent Office
Prior art keywords
ankylostome
inhibitor
plate
plate inhibitor
ankylostome plate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00918509A
Other languages
German (de)
English (en)
Other versions
EP1165598A1 (fr
Inventor
Michael Cappello
Robert C Chadderdon
Valle Antonio Del
Lisa M Harrison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of EP1165598A1 publication Critical patent/EP1165598A1/fr
Publication of EP1165598A4 publication Critical patent/EP1165598A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP00918509A 1999-03-31 2000-03-30 Inhibiteur des plaquettes d'ankylostome Withdrawn EP1165598A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12723999P 1999-03-31 1999-03-31
US127239P 1999-03-31
PCT/US2000/008519 WO2000058341A1 (fr) 1999-03-31 2000-03-30 Inhibiteur des plaquettes d'ankylostome

Publications (2)

Publication Number Publication Date
EP1165598A1 EP1165598A1 (fr) 2002-01-02
EP1165598A4 true EP1165598A4 (fr) 2002-10-30

Family

ID=22429047

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00918509A Withdrawn EP1165598A4 (fr) 1999-03-31 2000-03-30 Inhibiteur des plaquettes d'ankylostome

Country Status (5)

Country Link
EP (1) EP1165598A4 (fr)
JP (1) JP2002539817A (fr)
AU (1) AU3930800A (fr)
CA (1) CA2367424A1 (fr)
WO (1) WO2000058341A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2623565A1 (fr) 2005-09-28 2007-04-05 Biovascular, Inc. Methodes et compositions servant a bloquer l'adherence plaquettaire et cellulaire, la migration cellulaire et l'inflammation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789178A (en) * 1992-05-11 1998-08-04 Corvas International, Inc. Neutrophil inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9322576D0 (en) * 1993-11-02 1993-12-22 Univ Nottingham Antihaemostatic agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789178A (en) * 1992-05-11 1998-08-04 Corvas International, Inc. Neutrophil inhibitors

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHADDERDON ROBERT C ET AL: "The hookworm platelet inhibitor: Functional blockade of integrins GPIIb/IIIa (alphaIIbbeta3) and GPIa/IIa (alpha2beta1) inhibits platelet aggregation and adhesion in vitro.", JOURNAL OF INFECTIOUS DISEASES, vol. 179, no. 5, May 1999 (1999-05-01), pages 1235 - 1241, XP002210470, ISSN: 0022-1899 *
HAWDON J M ET AL: "ANCYLOSTOMA SECRETED PROTEIN 2: CLONING AND CHARACTERIZATION OF A SECOND MEMBER OF A FAMILY OF NEMATODE SECRETED PROTEINS FROM ANCYLOSTOMA CANINUM", MOLECULAR AND BIOCHEMICAL PARASITOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 99, no. 2, 30 April 1999 (1999-04-30), pages 149 - 165, XP001005293, ISSN: 0166-6851 *
MOYLE MATTHEW ET AL: "A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 269, no. 13, 1994, pages 10008 - 10015, XP002210469, ISSN: 0021-9258 *
See also references of WO0058341A1 *

Also Published As

Publication number Publication date
AU3930800A (en) 2000-10-16
WO2000058341A1 (fr) 2000-10-05
EP1165598A1 (fr) 2002-01-02
JP2002539817A (ja) 2002-11-26
CA2367424A1 (fr) 2000-10-05

Similar Documents

Publication Publication Date Title
PT1224195E (pt) C-aril-glicosidos inibidores de tgls2
EP1147107A4 (fr) Inhibiteurs d'angiogenese
EE200200273A (et) Uudsed diabeedivastased agensid
PL360404A1 (pl) 3'-proleki 2'-dezoksy-beta-L-nukleozydów
PT1181017E (pt) Inibidores de metaloproteases
EP1181122A4 (fr) Matieres d'alliage
NO20016319L (no) VLA-4 inhibitor-forbindelser
PT1194404E (pt) Inibidores de aspartil-protease
DE50010487D1 (de) Plattenreaktor
DE10083270D2 (de) Belagträgerplatte
EP1230494A4 (fr) Contrefiche d'ajustement
FR2815093B1 (fr) Installation d'embrayage
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
ID28480A (id) Aparatus penggerak piringan
ATE352210T1 (de) Verhinderung des festklebens von hartkonfekten
FR2796829B1 (fr) Plaque d'osteotomie tibiale
ID25700A (id) Unit penggerak piringan
EP1144305A4 (fr) NOUVEAUX INHIBITEURS DE sPLA 2
EP1192168A4 (fr) Galectine 11
GB2389113B (en) B-secretase inhibitor
DE50013313D1 (de) Verdampferplatine
DE59909685D1 (de) Plattenventil
EP1165598A4 (fr) Inhibiteur des plaquettes d'ankylostome
DK1224179T3 (da) Natrium-hydrogen-udbytter type 1-inhibitorkrystaller
EP1354589A4 (fr) Inhibiteurs d'angiogenese

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011005

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20020916

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20040301